An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD
- 1 August 1998
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 92 (8), 993-999
- https://doi.org/10.1016/s0954-6111(98)90343-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (07457598, 08457204)
This publication has 26 references indexed in Scilit:
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.The Journal of Experimental Medicine, 1989
- Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesisThe Journal of Pathology, 1984
- Cell Turnover in Pulmonary TissuesNature, 1962
- Simple Standard Exercise Test for Measuring Exertion DyspnoeaBMJ, 1952